AI assistant
Sending…
Anteris Technologies Global Corp. — Capital/Financing Update 2010
Mar 2, 2010
33869_rns_2010-03-02_484487da-cd75-442b-a962-bfbea81b61bd.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [594 x 64] intentionally omitted <==
Innovative BioMedical Devices
Level 11, 225 St Georges Terrace bioMD Limited ABN 35 088 221 078 Perth, Western Australia 6000 PO Box 7209, Cloisters Square Western Australia 6850
Telephone (08) 9262 6777 Facsimile (08) 9322 3433
ANNOUNCEMENT TO THE AUSTRALIAN STOCK EXCHANGE
1 of 1 page
3 March 2010
Company Announcements Office Australian Stock Exchange Limited 10[th] Floor, 20 Bond Street SYDNEY NSW 2000
Dear Sir/Madam
RIGHTS ISSUE TIMETABLE (AMENDED)
The indicative timetable for the pro-rata non renounceable rights issue, originally announced on 25 February 2010 has been amended as follows:
| February 2010 has been amended as follows: | |
|---|---|
| Lodgement of the Offer Document with ASIC and ASX | 25 February 2010 |
| Existing Shares trade ex-entitlement to participate in the Offer | 4 March 2010 |
| Record Date to determine entitlement to participate in the Offer | 11 March 2010 |
| Despatch of Offer Document and Entitlement and Acceptance Forms | 17 March 2010 |
| Closing Date for acceptance of applications for New Options | 31 March 2010 |
| New Options commence trading on a deferred settlement basis | 1 April 2010 |
| Allotment date and despatch date of Holding Statements | 12 April 2010 |
| Date of quotation by ASX of New Options on a normal settlement basis | 13 April 2010 |
Yours faithfully
==> picture [78 x 58] intentionally omitted <==
Caroline Bentley Company Secretary
==> picture [594 x 42] intentionally omitted <==
More from Anteris Technologies Global Corp.
Director's Dealing
2026
Jun 5
Share Issue/Capital Change
2026
Jun 5
Share Issue/Capital Change
2026
Jun 2
Capital/Financing Update
2026
May 26
Capital/Financing Update
2026
May 24
Capital/Financing Update
2026
May 22
Share Issue/Capital Change
2026
May 22
Director's Dealing
2026
May 17
Interim / Quarterly Report
2026
May 15
Board/Management Information
2026
May 12